Abstract
When a virus spreads, it may mutate into, e.g., vaccine resistant or fast spreading sub-types, as was the case for the Danish Cluster-5 mink, the British B.1.1.7, and the South African 501Y.V2 variants of the SARS-CoV-2 virus. A way to handle such spreads is through a containment strategy, where the population in the affected area is isolated until the spread has been stopped. Under such circumstances, it is important to monitor whether the mutated virus is extinct via massive testing for the virus sub-type. If successful, the strategy will lead to lower and lower numbers of the sub-type, and it will eventually die out. An important question is, for how long time one should wait to be sure the sub-type is extinct? We use a hidden Markov model for infection spread and an approximation of a two stage sampling scheme to infer the probability of extinction. The potential of the method is illustrated via a simulation study. Finally, the model is used to assess the Danish containment strategy when SARS-CoV-2 spread from mink to man during the summer of 2020, including the Cluster-5 sub-type. In order to avoid further spread and mink being a large animal virus reservoir, this situation led to the isolation of seven municipalities in the Northern part of the country, the culling of the entire Danish 17 million large mink population, and a bill to interim ban Danish mink production until the end of 2021.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors gratefully acknowledge the Novo Nordisk Foundation's support to the COVID-19- CTRL Project and the Poul Due Jensen Foundation's support through the BEO-COVID Project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The manuscript develops a mathematical model for modelling the spread of infectious disease, and applies it to publically available Covid-19 data, hence no ethical approval is required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data on the weekly number of PCR tests and infected people from Danish Covid-19 test centers are publicly available from Statens Serum Institut at: https://covid19.ssi.dk/overvagningsdata/ download-fil-med-overvaagningdata Data on the number of WGS samples per week in the North Denmark region were obtained from the Danish Covid-19 Genome Consortium at: https://www.covid19genomics.dk/statistics Data on Danish cluster5 samples were obtained from a dedicated S:Y453F (mink mutation) build at Nextstrain[4]: https://nextstrain.org/groups/neherlab/ncov/S.Y453F?c=gt-S_453&f_clade_membership=Mink.Cluster5&;f_region=Europe Population sizes in the municipalities in the North Denmark region were obtained from Statbank, Statistics Denmark: https://www.dst.dk/en/Statistik/emner/befolkning-og-valg/befolkning-og-befolkningsfremskrivning
